A. V. Moorman

Publication List Details

Period

2001 - 2008

Number

33

Co-Authors

Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MIRD) clearance in childhood lymphoblastic leukaemia (ALL) (2008)

Moorman, A.V., Richards, S.M., Hancock, J.P., Mitchell, C.D., Vora, A.J., Harrison, C.J., ...

Although both MRD and karyotype are powerful determinants of outcome in childhood ALL, few studies have examined the kinetics of MRD clearance by cytogenetics. In ALL2003, patients are stratified by...

t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)2 (2008)

Russell, L.J., Akasaka, T., Majid, A., Sugimoto, K.J., Karran, E.L., Nagel, I., ...

Translocations involving the immunoglobulin heavy chain locus (IGH@) at chromosome band 14q32 are common in mature B-cell neoplasms, but are rare in B-cell precursor acute lymphoblastic leukemia...

Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization (2007)

Strefford, J.C., Worley, H., Barber, K., Wright, S., Stewart, A.R.M., Robinson, H.M., ...

Chromosomal abnormalities are important for the classification and risk stratification of patients with acute lymphoblastic leukemia (ALL). However, approximately 30% of childhood and 50% of adult...

Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)30 (2007)

Moorman, A.V., Richards, S.M., Robinson, H.M., Strefford, J.C., Gibson, B.E.S., Kinsey, S.E., ...

Patients with acute lymphoblastic leukemia (ALL) and an intrachromosomal amplification of chromosome 21 (iAMP21) comprise a novel and distinct biological subgroup. We prospectively screened 1630...

Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization (2007)

Strefford, J.C., Worley, H., Barber, K., Wright, S., Stewart, A.R.M., Robinson, H.M., ...

Chromosomal abnormalities are important for the classification and risk stratification of patients with acute lymphoblastic leukemia (ALL). However, approximately 30% of childhood and 50% of adult...

Population-based demographic study of karyotypes in 1709 patients with adult Acute Myeloid Leukemia (2006)

Sanderson, R.N., Johnson, P.R., Moorman, A.V., Roman, E., Willett, E., Taylor, P.R., ...

Few large demographic studies of acute myeloid leukemia (AML) are derived from population-based registries. Demographic and karyotypic data were provided for AML cases from two regional leukemia...

No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities (2005)

Moorman, A.V., Raimondi, S.C., Pui, C.H., Baruchel, A., Biondi, A., Carroll, A.J., ...

This study characterized the additional chromosomal abnormalities (ACA) associated with 11q23 rearrangements in 450 infants and children with acute lymphoblastic leukemia (ALL) and examined the...

Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study (2005)

Harrison, C.J., Moorman, A.V., Barber, K.E., Broadfield, Z.J., Cheung, K.L., Harris, R.L., ...

Interphase fluorescence in situ hybridization (iFISH) was used independently to reveal chromosomal abnormalities of prognostic importance in a large, consecutive series of children (n = 2367) with...

Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia (2005)

Robinson, H.M., Martineau, M., Harris, R.L., Barber, K.E., Jalali, G.R., Moorman, A.V., ...

Deletions from the derivative chromosome 9, der(9), of the translocation, t(9;22)(q34;q11), at the site of the ABL/BCR fusion gene, have been demonstrated by fluorescence in situ hybridisation...

Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial (2005)

Roy, A., Cargill, A., Love, S., Moorman, A.V., Stoneham, S., Lim, A., ...

A retrospective analysis of children with first relapse of acute lymphoblastic leukaemia (ALL), treated on the UKALL R2 protocol at four different hospitals, between June 1995 and December 2002 was...

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years (2005)

Bowen, D.T., Frew, M.E., Hills, R., Gale, R.E., Wheatley, K., Groves, M.J., ...

The pathogenesis of acute myeloid leukemia (AML) involves the cooperation of mutations promoting proliferation/survival and those impairing differentiation. The RAS pathway has been implicated as a...

Breakpoints of variant 9;22 translocations in chronic myeloid leukemia locate preferentially in the CG-richest regions of the genome (2005)

Fisher, A.M., Strike, P., Scott, C., Moorman, A.V.

From 5% to 10% of 9;22 translocations in chronic myeloid leukemia (CML) are reported to occur in variant form, that is, with the involvement of other regions of the genome in 3-way or more...

Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases (2003)

Harewood, L., Robinson, H., Harris, R., Al-Obaidi, M.J., Jalali, G.R., Martineau, M., ...

This study identifies multiple copies of the AML1 gene on a duplicated chromosome 21, dup(21), as a recurrent abnormality in acute lymphoblastic leukemia (ALL). Clusters of AML1 signals were visible...

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome (2003)

Robinson, H.M., Broadfield, Z.J., Cheung, K.L., Harewood, L., Harris, R.L., Jalali, G.R., ...

A total of 28 children and nine adults with relapsed T-ALL were analyzed for the configuration of their T-cell receptor (TCR) and TAL1 genes at diagnosis and relapse to evaluate their stability...

Age-specific incidence rates for cytogenetically-defined subtypes of acute myeloid leukaemia (2002)

Moorman, A.V., Roman, E., Cartwright, R.A., Morgan, G.J.

It is generally considered that most cancers arise following the accumulation of several genetic events and that as a consequence its incidence increases with age. We report a cytogenetic subgroup of...

Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups (2002)

Moorman, A.V., Roman, E., Cartwright, R.A., Morgan, G.J.

Cytogenetically-defined subgroups of acute myeloid leukaemia have distinct biologies, clinical features and outcomes. Evidence from therapy-related leukaemia suggests that chromosomal abnormalities...

Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalities (2002)

Lebailly, P., Willett, E.V., Moorman, A.V., Roman, E., Cartwright, R., Morgan, G.J., ...

Acute myeloid leukaemia (AML) cases with different chromosomal abnormalities may reflect different aetiologies. Benzene exposure, from a number of sources including smoking, is one risk factor for...

Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapyinduced leukemia (2001)

Allan, J.M., Wild, C.P., Rollinson, S., Willett, E.V., Moorman, A.V., Dovey, G.J., ...

Glutathione S-transferases (GSTs) detoxify potentially mutagenic and toxic DNA-reactive electrophiles, including metabolites of several chemotherapeutic agents, some of which are suspected human...

Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapyinduced leukemia (2001)

Allan, J.M., Wild, C.P., Rollinson, S., Willett, E.V., Moorman, A.V., Dovey, G.J., ...

Glutathione S-transferases (GSTs) detoxify potentially mutagenic and toxic DNA-reactive electrophiles, including metabolites of several chemotherapeutic agents, some of which are suspected human...

Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapyinduced leukemia (2001)

Allan, J.M., Wild, C.P., Rollinson, S., Willett, E.V., Moorman, A.V., Dovey, G.J., ...

Glutathione S-transferases (GSTs) detoxify potentially mutagenic and toxic DNA-reactive electrophiles, including metabolites of several chemotherapeutic agents, some of which are suspected human...

Polymorphism in glutathione S-transferase is associated with susceptibility to chemotherapy-induced leukemia (2001)

Allan, J.M., Wild, C.P., Rollinson, S., Willett, E.V., Moorman, A.V., Dovey, G.J., ...

Glutathione S-transferases (GSTs) detoxify potentially mutagenic and toxic DNA-reactive electrophiles, including metabolites of several chemotherapeutic agents, some of which are suspected human...

Age-specific incidence rates for cytogenetically-defined subtypes of acute myeloid leukaemia

Moorman, A V, Roman, E, Cartwright, R A, Morgan, G J

It is generally considered that most cancers arise following the accumulation of several genetic events and that as a consequence its incidence increases with age. We report a cytogenetic subgroup of...

Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups

Moorman, A V, Roman, E, Cartwright, R A, Morgan, G J

Cytogenetically-defined subgroups of acute myeloid leukaemia have distinct biologies, clinical features and outcomes. Evidence from therapy-related leukaemia suggests that chromosomal abnormalities...